Richard J M Emanuel (born 29 October 1967) is a British businessman and investor. He founded his first company DX Communications at the age of 23, which grew from a one person start-up to an organisation of over 1,000 people within a 5-year period. The company was acquired by British Telecom's subsidiary BT Cellnet in September 1999. Following this, Emanuel has gone on to build a number of successful companies.
Emanuel remains active in the technology sector, with a focus on working with high-growth companies. In March 2020 he joined the Executive Team of MARSS Group, a technology security company, and one of the fastest growing privately owned businesses in Europe. [1] He is also the non-exec Chairman of EIP Limited, a Insurtech, supplying corporate clients with subscription insurance and claims management. [2]
Alongside this, Emanuel also has a personal interest in the healthy ageing sector. In 2016 he co-founded Lumity, [3] and in 2020 co-founded Brain Health Network [4] - an organisation dedicated to helping people keep their brain healthy and lower the risk of neurodegenerative diseases such as Alzheimer's (the most common type of dementia). [5] He has received various awards and recognition during his business career, including an MBE received from Queen Elizabeth II in 2000. He has also been a member of the Young Presidents' Organization [6] since 2000, and is a past chairman of their Monaco chapter.
Richard Emanuel was born on 29 October 1967, [7] to academics Lois Emanuel (née Metcalfe) and Dr Ronald Emanuel. [8] He spent his early life in the city of Glasgow attending Hutchesons' Grammar School. [9] He was active in sports, excelling in both boxing and swimming.
In 1990, Emanuel founded his first company, DX Communications, which operated in the cellular telecoms sector. [10] [11] The company was a one person start-up and was funded initially by his own savings [12] and a £500 loan from his grandmother, Ivy. In the years that followed, DX grew to an organisation of over 1,000 people, with operations across the UK. In September 1999, the company was acquired by British Telecom's subsidiary BT Cellnet for a reported £42m. [10] Emanuel remained active in the telecom and technology sector through the 2000s, building a number of companies in mainland Europe and North Africa. [13]
Emanuel's primary business and investment focus is working with high-growth technology companies.
In March 2020 he joined the Executive Team of MARSS Group, a technology company focused on the protection of lives and critical infrastructure, and one of the fastest-growing companies in Europe. [14] His role at the company is Executive Chairman.
He also has a personal interest in the healthy ageing space. He is the co-founder of Lumity Life, a company providing a healthy ageing and immune support supplement range, and in 2020, co-founded Brain Health Network, an organisation dedicated to helping people lower their risk of dementia and to keep their brain healthy as they age. He became interested in the emerging research indicating that it is possible to significantly lower the risk of developing neurodegenerative diseases such as Alzheimer’s (the most common type of dementia) – in part by maintaining a healthy brain. [15] This area is of personal importance for Emanuel, whose mother had dementia.
In 2008 Emanuel married Judith Halmshaw, [16] a businesswoman and founder of the men's yoga wear brand Warrior Addict [17] in Beaulieu-Sur-Mer in the South of France. The couple, who have two children, a girl and a boy, lived together in Monaco before they separated on amicable terms in 2016.[ citation needed ]
Emanuel has received various business awards and honours throughout his career including an MBE presented by Queen Elizabeth at Buckingham Palace in 2000. [18] [19]
Dementia is the general name for a decline in cognitive abilities that impacts a person's ability to perform everyday activities. This typically involves problems with memory, thinking, and behavior. Aside from memory impairment and a disruption in thought patterns, the most common symptoms include emotional problems, difficulties with language, and decreased motivation. The symptoms may be described as occurring in a continuum over several stages. Dementia ultimately has a significant effect on the individual, caregivers, and on social relationships in general. A diagnosis of dementia requires the observation of a change from a person's usual mental functioning and a greater cognitive decline than what is caused by normal aging.
Alzheimer's Society is a United Kingdom care and research charity for people with dementia and their carers. It operates in England, Wales and Northern Ireland, while its sister charities Alzheimer Scotland and Alzheimer Society of Ireland cover Scotland and the Republic of Ireland respectively.
Cerebral atrophy is a common feature of many of the diseases that affect the brain. Atrophy of any tissue means a decrement in the size of the cell, which can be due to progressive loss of cytoplasmic proteins. In brain tissue, atrophy describes a loss of neurons and the connections between them. Brain atrophy can be classified into two main categories: generalized and focal atrophy. Generalized atrophy occurs across the entire brain whereas focal atrophy affects cells in a specific location. If the cerebral hemispheres are affected, conscious thought and voluntary processes may be impaired.
Memory disorders are the result of damage to neuroanatomical structures that hinders the storage, retention and recollection of memories. Memory disorders can be progressive, including Alzheimer's disease, or they can be immediate including disorders resulting from head injury.
Lawrence J. Whalley MB, BS, MD, DPM, FRCP(E), FRC Psych was formerly the Crombie Ross Professor of Mental Health in the University of Aberdeen, Scotland, UK from 1992 to 2008. He remains professor emeritus at the University of Aberdeen and from 2010-2020 part-time professor of research at the University of the Highlands and Islands.
The Nun Study of Aging and Alzheimer's Disease is a continuing longitudinal study, begun in 1986, to examine the onset of Alzheimer's disease. David Snowdon, an Epidemiologist and the founding Nun Study investigator, started the Nun Study at the University of Minnesota, later transferring the study to the University of Kentucky in 1990. In 2008, with Snowdon's retirement, the study returned to the University of Minnesota. The Nun Study was very briefly moved from the University of Minnesota to Northwestern University in 2021 under the directorship of Dr. Margaret Flanagan. The Nun Study is currently housed at the University of Texas Health San Antonio in the Bigg's Institute for Alzheimer's and Neurodegenerative diseases under the continued directorship of Neuropathologist, Dr. Margaret Flanagan.
Alzheimer’s Disease International (ADI) is a not-for-profit, international federation of Alzheimer and dementia associations from around the world. The organization is in official relations with the World Health Organization (WHO). ADI advocates for people living with Alzheimer’s disease and all other types of dementia.
Mild cognitive impairment (MCI) is a neurocognitive disorder which involves cognitive impairments beyond those expected based on an individual's age and education but which are not significant enough to interfere with instrumental activities of daily living. MCI may occur as a transitional stage between normal aging and dementia, especially Alzheimer's disease. It includes both memory and non-memory impairments. The cause of the disorder remains unclear, as well as both its prevention and treatment, with some 50 percent of people diagnosed with it going on to develop Alzheimer's disease within five years. The diagnosis can also serve as an early indicator for other types of dementia, although MCI may remain stable or even remit.
The prevention of dementia involves reducing the number of risk factors for the development of dementia, and is a global health priority needing a global response. Initiatives include the establishment of the International Research Network on Dementia Prevention (IRNDP) which aims to link researchers in this field globally, and the establishment of the Global Dementia Observatory a web-based data knowledge and exchange platform, which will collate and disseminate key dementia data from members states. Although there is no cure for dementia, it is well established that modifiable risk factors influence both the likelihood of developing dementia and the age at which it is developed. Dementia can be prevented by reducing the risk factors for vascular disease such as diabetes, high blood pressure, obesity, smoking, physical inactivity and depression. A study concluded that more than a third of dementia cases are theoretically preventable. Among older adults both an unfavorable lifestyle and high genetic risk are independently associated with higher dementia risk. A favorable lifestyle is associated with a lower dementia risk, regardless of genetic risk. In 2020, a study identified 12 modifiable lifestyle factors, and the early treatment of acquired hearing loss was estimated as the most significant of these factors, potentially preventing up to 9% of dementia cases.
As populations age, caring for people with dementia has become more common. Elderly caregiving may consist of formal care and informal care. Formal care involves the services of community and medical partners, while informal care involves the support of family, friends, and local communities. In most mild-to-medium cases of dementia, the caregiver is a spouse or an adult child. Over the period of time, more professional care in the form of nursing and other supportive care may be required medically, whether at home or in a long-term care facility. There are evidence to show that case management can improve care for individuals with dementia and the experience of their caregivers. Furthermore, case management may reduce overall cost and institutional care in the medium term. Millions of people living in the United States take care of a friend or family member with Alzheimer’s disease or a related dementia.
The European Institute of Women's Health (EIWH) is a women's and family health policy development institution. It was established in 1996, primarily to ensure women's and indeed all aspects of family health and well being were on the European and national member parliament's agendas. The EIWH, is an NGO, established as a company, no shares. Its administrative office is based in Dublin, Ireland and it is a registered charity.
Wandering occurs when a person with dementia roams around and becomes lost or confused about their location. It is a common behavior that can cause great risk for the person, and is often the major priority for caregivers. It is estimated to be the most common form of disruption from people with dementia within institutions. Although it occurs in several types of dementia, wandering is especially common in people with Alzheimer's disease (AD). People with dementia often wander because they are stressed, looking for someone or something, attending to basic needs, engaging in past routines, or with visual-spatial problems. Other times, they may wander without aim at all.
Perminder Sachdev is an Indian neuropsychiatrist based in Australia. He is a professor of neuropsychiatry at the University of New South Wales (UNSW), co-director of the UNSW Centre for Healthy Brain Aging, and clinical director of the Neuropsychiatric Institute at the Prince of Wales Hospital, Sydney. He is considered a trailblazer in the field of neuropsychiatry. Sachdev's research interests include ageing, vascular cognitive disorders such as vascular dementia, and psychiatric disorders.
Ryman Healthcare Limited is a New Zealand retirement village and rest home operator. It is listed on the New Zealand Stock Exchange and is one of the largest companies listed on the NZX 50 Index.
The Queensland Brain Institute (QBI) is an Australian neuroscience research institute, located in Brisbane at the St Lucia campus of The University of Queensland (UQ). Founding director Professor Perry Bartlett established the QBI in 2003 with assistance from The University of Queensland, Queensland State Government, and Chuck Feeney, founder of The Atlantic Philanthropies. The purpose-built facility was commissioned in 2004 and on 19 November 2007, the building was opened by former Queensland Premier Anna Bligh.
Carol Elspeth Goodeve Brayne CBE is a British academic and the Professor of Public Health Medicine at the University of Cambridge and Chair of Wellcome's Population and Public Health Review Group. She is Director of the Cambridge Institute of Public Health. She is a special advisor for the Royal College of Physicians and a senior investigator at the National Institute for Health Research (NIHR).
Dementia and Alzheimer's disease in Australia is a major health issue. Alzheimer's disease is the most common type of dementia in Australia. Dementia is an ever-increasing challenge as the population ages and life expectancy increases. As a consequence, there is an expected increase in the number of people with dementia, posing countless challenges to carers and the health and aged care systems. In 2018, an estimated 376,000 people had dementia; this number is expected to increase to 550,000 by 2030 and triple to 900,000 by 2050. The dementia death rate is increasing, resulting in the shift from fourth to second leading cause of death from 2006 to 2015. It is expected to become the leading cause of death over the next number of years. In 2011, it was the fourth leading cause of disease burden and third leading cause of disability burden. This is expected to remain the same until at least 2020.
Sabina Brennan is an Irish neuroscientist, psychologist, and former television actress. She is currently an adjunct assistant professor working at Trinity College Dublin.
The Women's Healthy Ageing Project (WHAP) is the longest ongoing medical research project examining the health of Australian women. Its landmark studies concern women's heart and brain health, a long-neglected area of specialised research.
Cassandra Szoeke is an Australian medical researcher and practicing physician in internal medicine, with a sub-specialisation in neurology.